-
公开(公告)号:US20100298274A1
公开(公告)日:2010-11-25
申请号:US12309787
申请日:2007-07-27
申请人: Adrian Hughes , Rakesh Kapoor , Jeanette M. Fusick
发明人: Adrian Hughes , Rakesh Kapoor , Jeanette M. Fusick
IPC分类号: A61K31/661 , A61K31/202 , A61P25/00 , A61P13/08 , A23D9/00 , C11B5/00 , A23L1/40 , A23C19/00 , A23G9/00 , A23L1/24 , A23L1/00 , A23G3/20
CPC分类号: C11B5/0085 , A23L33/105 , A23L33/12 , C11B5/0007 , C11B5/0071
摘要: A composition comprises a fat phase wherein the fat phase comprises: more than 10 wt. % DHA and/or EPA or derivatives thereof; or more than 5 wt. % GLA or a derivative thereof; or more than 10 wt. % of GLA, EPA and/or DHA in total or derivatives thereof; and secoisolariciresinol (SECO) or a derivative thereof, with the proviso that when the composition comprises GLA, the composition is substantially free of isoflavones. The composition and mixtures or blends comprising the composition may be used for the treatment of PMS and prostate conditions.
摘要翻译: 组合物包含脂肪相,其中脂肪相包含:大于10重量% %DHA和/或EPA或其衍生物; 或大于5wt。 %GLA或其衍生物; 或大于10重量% %的GLA,EPA和/或DHA或其衍生物; 和双异吲哚啉醇(SECO)或其衍生物,条件是当组合物包含GLA时,组合物基本上不含异黄酮。 包含该组合物的组合物和混合物或共混物可用于治疗PMS和前列腺病症。